Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways.
Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways.
复制标题
DOI:
10.1155/2021/6644751
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Yan G
中科院分区:
文献类型:
--
作者:
Piao Y;Jiang J;Wang Z;Wang C;Jin S;Li L;Li L;Piao H;Jin Z;Zhu L;Yan G
Glaucocalyxin A (GLA) has various pharmacological effects like antioxidation, immune regulation, and antiatherosclerosis. Here, in this study, the effect and mechanism of GLA on mast cell degranulation were studied. The results of the anti-DNP IgE-mediated passive cutaneous anaphylaxis (PCA) showed that GLA dramatically inhibited PCA in vivo, as evidenced by reduced Evans blue extravasation and decreased ear thickness. In addition, GLA significantly reduced the release of histamine and β-hexosaminidase, calcium influx, cytokine (IL-4, TNF-α, IL-1β, IL-13, and IL-8) production in the RBL-2H3 (rat basophilic leukemia cells), and RPMCs (peritoneal mast cells) in vitro. Moreover, we further investigated the regulatory mechanism of GLA on antigen-induced mast cells by Western blot, which showed that GLA inhibited FcεRI-mediated signal transduction and invalidated the phosphorylation of Syk, Fyn, Lyn, Gab2, and PLC-γ1. In addition, GLA inhibited the recombinant mouse high mobility group protein B1- (HMGB1-) induced mast cell degranulation through limiting nuclear translocation of NF-κBp65. Treatment of mast cells with siRNA-HMGB1 significantly inhibited HMGB1 levels, as well as MyD88 and TLR4, decreased intracellular calcium levels, and suppressed the release of β-hexosaminidase. Meanwhile, GLA increased NrF2 and HO-1 levels by activating p38MAPK phosphorylation. Consequently, these data suggest that GLA regulates the NrF2/HO-1 signaling pathway through p38MAPK phosphorylation and inhibits HMGB1/TLR4/NF-κB signaling pathway to reduce mast cell degranulation and allergic inflammation. Our findings could be used as a promising therapeutic drug against allergic inflammatory disease.
登录
查看更多内容
影响因子:
4.6
作者:
Ye J;Piao H;Jiang J;Jin G;Zheng M;Yang J;Jin X;Sun T;Choi YH;Li L;Yan G
通讯作者:
Yan G
DOI:
10.1016/j.coi.2017.10.012
发表时间:
2018-12-01
期刊:
Conrado
影响因子:
--
作者:
Espinoza Freire, Eudaldo Enrique
通讯作者:
Espinoza Freire, Eudaldo Enrique
影响因子:
4
作者:
Dera, Ayed;Rajagopalan, Prasanna;Chandramoorthy, Harish C.
通讯作者:
Chandramoorthy, Harish C.
影响因子:
7.3
作者:
Kim, Min-Jong;Je, In-Gyu;Kim, Sang-Hyun
通讯作者:
Kim, Sang-Hyun
影响因子:
7.3
作者:
Krystel-Whittemore M;Dileepan KN;Wood JG
通讯作者:
Wood JG